|

IMSA101 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Texas Southwestern Medical Center1

Indications

  • Metastatic Renal Cell Carcinoma (mRCC)1
  • OligoProgressive Metastatic Disease1
  • Cancer1

Dallas, Texas1 trial

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

University of Texas Southwestern Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.